Home
Conditions
Lymphoma, T-Cell

Clinical trial condition

Lymphoma, T-Cell

Explore clinical trials studying Lymphoma, T-Cell. Study availability and eligibility vary by location and protocol.

694 public trials 105 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, T-Cell trial results

Completed

Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma

NCT00059839

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham Birmingham, Alabama, United States

Phoenix Children's Hospital Phoenix, Arizona, United States

Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

Southern California Permanente Medical Group Downey, California, United States

View all 159 locations

View Trial Details

Completed

EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer

NCT00004258

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +83 more
Locations: Indiana University Cancer Center Indianapolis, Indiana, United States

View Trial Details

Completed

Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer

NCT00589563

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +70 more
Locations: Banner Good Samaritan Medical Center Phoenix, Arizona, United States

City of Hope Comprehensive Cancer Center Duarte, California, United States

View Trial Details

Completed

Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors

NCT00003107

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +116 more
Locations: Indiana University Cancer Center Indianapolis, Indiana, United States

View Trial Details

Completed

SAHA + CHOP in Untreated T-cell Non-Hodgkin's Lymphoma

NCT00787527

Conditions: Enteropathy-Associated T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

A Structured Walking Program or Standard Therapy in Cancer Patients Undergoing a Donor Bone Marrow Transplant

NCT00445731

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +96 more
Locations: Not specified

View Trial Details

Completed

A Phase 1 Study of SP-02L in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL) in Korea

NCT01689220

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Samsung Medical Center Seoul, South Korea

View Trial Details

Completed

CPG 7909 + Local Radiotherapy in Recurrent Low-Grade Lymphomas

NCT00185965

Conditions: Bacterial Infections and Mycoses, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Completed

17-AAG in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Hodgkin's Lymphoma

NCT00117988

Conditions: Anaplastic Large Cell Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +13 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

In Vitro Evaluation of Immune Responses in Cutaneous T-Cell Lymphoma (CTCL)

NCT00177190

Conditions: Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States

View Trial Details

Lymphoma, T-Cell

Lymphoma, T-Cell trial results

Related conditions